Follow-The-Filings

ABBV AbbVie

AbbVie earnings company data as of 5:23 PM ET 9/4

  • 1 of 1 EPS beats
  • 12 Owners
  • Rank #82
  • Max 2.8%
  • Master 0.01%

History

2 periods · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q4 30 Oct EPS 3.87 — —
Rev $17.31B — —
FY2026 Q3 31 Jul EPS 3.60 3.65 Beat +1.4%
Rev $16.78B $16.99B Beat +1.2%

Who owns this now

Largest portfolio weights among featured holders · max 2.8% (Torray Investment Partners) · not free-float ownership

full dossier →
  1. Torray Investment Partners reduce 2.8%
  2. David Katz reduce 0.80%
  3. Glenview Capital Management new 0.68%
  4. Kentucky Trust Co. reduce 0.65%
  5. Murphy Pohlad reduce 0.31%
  6. Lewis Sanders reduce 0.12%

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Aug 14, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period May 8, 2026 · 2 forms Filing Doc

20 more insider forms →

Updated 1 day ago Source: SEC EDGAR submissions All on EDGAR

Consensus estimates · SEC filings remain the official record · not investment advice